• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤白细胞碎裂性血管病:法国观察性研究包括治疗选择。

Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.

机构信息

Department of Dermatology, Hôpital Tenon, APHP, Paris, France.

出版信息

Acta Derm Venereol. 2018 Oct 10;98(9):842-847. doi: 10.2340/00015555-2965.

DOI:10.2340/00015555-2965
PMID:29738044
Abstract

Livedoid vasculopathy is a rare thrombotic cutaneous disease. This observational study aimed to assess the clinical and biological features of livedoid vasculopathy and the efficacy of treatments. Patients enrolled had typical livedoid vasculopathy both clinically and histologically. Investigation of thrombophilia was performed. Electromyography was undertaken in the presence of symptoms suggesting peripheral neuropathy. Eighteen women and 8 men were included, with a mean age of 35.5 years at onset. Twenty patients had at least one thrombophilia factor. Ten patients had a peripheral neuropathy with 2 of these patients demonstrating a specific thrombo-occlusive vasculopathy on muscle biopsy. Anticoagulation with low molecular weight heparin was the most prescribed therapy and was associated with the best outcome (effective in 14 patients). Eight patients had severe disease refractory to anticoagulation and required intravenous immunoglobulins, producing a good response in 6 patients.

摘要

皮肤白细胞碎裂性血管病是一种罕见的血栓性皮肤疾病。本观察性研究旨在评估皮肤白细胞碎裂性血管病的临床和生物学特征,以及治疗的疗效。纳入的患者在临床和组织学上均具有典型的皮肤白细胞碎裂性血管病表现。进行了血栓形成倾向的检查。在出现提示周围神经病的症状时,进行了肌电图检查。共纳入 18 名女性和 8 名男性患者,发病时的平均年龄为 35.5 岁。20 名患者存在至少 1 种血栓形成倾向因素。10 名患者存在周围神经病,其中 2 名患者的肌肉活检显示存在特发性血栓闭塞性血管病。低分子肝素抗凝治疗是最常开具的治疗方法,且疗效最佳(14 名患者有效)。8 名患者疾病严重,对抗凝治疗无反应,需要静脉注射免疫球蛋白,其中 6 名患者的反应良好。

相似文献

1
Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.皮肤白细胞碎裂性血管病:法国观察性研究包括治疗选择。
Acta Derm Venereol. 2018 Oct 10;98(9):842-847. doi: 10.2340/00015555-2965.
2
Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review.脉冲式静脉注射免疫球蛋白治疗难治性溃疡性类脂质渐进性坏死性血管病:7例病例及文献综述
Dermatol Ther. 2015 Sep-Oct;28(5):287-90. doi: 10.1111/dth.12233. Epub 2015 Apr 6.
3
Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.狼疮抗凝物和 MTHFR 突变患者的皮肤白细胞碎裂性血管病:低分子肝素治疗。
J Thromb Thrombolysis. 2012 Nov;34(4):541-4. doi: 10.1007/s11239-012-0743-5.
4
Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.静脉注射免疫球蛋白治疗类脂质渐进性坏死性血管炎的疗效:11 例患者的长期随访。
J Am Acad Dermatol. 2014 Oct;71(4):738-44. doi: 10.1016/j.jaad.2014.05.039. Epub 2014 Jul 9.
5
Livedoid vasculopathy and peripheral neuropathy: A retrospective cohort study of 55 Chinese patients and literature review.皮肤白细胞碎裂性血管病伴发周围神经病:55 例中国患者的回顾性队列研究及文献复习。
Int Wound J. 2023 May;20(5):1498-1505. doi: 10.1111/iwj.14004. Epub 2022 Nov 4.
6
Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series.静脉注射免疫球蛋白治疗难治性类脂质渐进性坏死性血管病:病例系列分析
Dermatol Ther. 2020 Mar;33(2):e13229. doi: 10.1111/dth.13229. Epub 2020 Feb 4.
7
Treatment for Livedoid Vasculopathy: A Systematic Review.静脉性血管病的治疗:系统综述。
JAMA Dermatol. 2018 Feb 1;154(2):193-202. doi: 10.1001/jamadermatol.2017.4374.
8
Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy.38例类脂质渐进性坏死患者血清脂蛋白(a)水平及皮肤表达分析。
J Cutan Pathol. 2017 Dec;44(12):1033-1037. doi: 10.1111/cup.13043. Epub 2017 Oct 13.
9
Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review.静脉注射免疫球蛋白治疗难治性溃疡性结节性血管炎:五例病例及文献复习。
Int J Dermatol. 2013 Sep;52(9):1135-9. doi: 10.1111/j.1365-4632.2012.05826.x. Epub 2013 Mar 14.
10
Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.成功用小剂量华法林治疗类脂蛋白血管病伴发周围神经病 1 例
J Dermatol. 2010 Jan;37(1):98-101. doi: 10.1111/j.1346-8138.2009.00754.x.

引用本文的文献

1
Baricitinib Successfully Treated a Teenager with Refractory Livedoid Vasculopathy: A Case Report and Literature Review.巴瑞替尼成功治疗一名难治性类脂质渐进性坏死性血管病青少年:病例报告及文献综述
J Inflamm Res. 2025 Feb 1;18:1471-1477. doi: 10.2147/JIR.S495481. eCollection 2025.
2
Identification of Challenging Diagnostic Factors in Livedoid Vasculopathy: A Retrospective Study.萎缩性硬化性苔藓中具有挑战性的诊断因素识别:一项回顾性研究。
Clin Cosmet Investig Dermatol. 2024 Aug 2;17:1747-1756. doi: 10.2147/CCID.S466449. eCollection 2024.
3
Approach to the Atypical Wound.
非典型创面处理方法。
Am J Clin Dermatol. 2024 Jul;25(4):559-584. doi: 10.1007/s40257-024-00865-0. Epub 2024 May 14.
4
The Histopathology of Leg Ulcers.腿部溃疡的组织病理学
Dermatopathology (Basel). 2024 Jan 29;11(1):62-78. doi: 10.3390/dermatopathology11010007.
5
A comprehensive review on pathogenesis, associations, clinical findings, and treatment of livedoid vasculopathy.关于萎缩性硬化性苔藓样血管病的发病机制、关联因素、临床发现及治疗的全面综述。
Front Med (Lausanne). 2022 Dec 8;9:993515. doi: 10.3389/fmed.2022.993515. eCollection 2022.
6
Baricitinib is potentially effective in the treatment of refractory livedoid vasculopathy.巴瑞替尼可能对治疗难治性类脂蛋白血管病变有效。
Front Immunol. 2022 Oct 27;13:1008392. doi: 10.3389/fimmu.2022.1008392. eCollection 2022.
7
Livedoid vasculopathy and peripheral neuropathy: A retrospective cohort study of 55 Chinese patients and literature review.皮肤白细胞碎裂性血管病伴发周围神经病:55 例中国患者的回顾性队列研究及文献复习。
Int Wound J. 2023 May;20(5):1498-1505. doi: 10.1111/iwj.14004. Epub 2022 Nov 4.
8
Livedoid vasculopathy: A review with focus on terminology and pathogenesis.皮肤白细胞碎裂性血管病:术语和发病机制综述。
Vasc Med. 2022 Dec;27(6):593-603. doi: 10.1177/1358863X221130380. Epub 2022 Oct 26.
9
Livedoid vasculopathy - A diagnostic and therapeutic challenge.萎缩性硬化性苔藓样血管病——诊断与治疗的挑战。
Front Med (Lausanne). 2022 Oct 3;9:1012178. doi: 10.3389/fmed.2022.1012178. eCollection 2022.
10
Botulinum toxin-A: A novel treatment for livedoid vasculopathy.肉毒杆菌毒素A:一种治疗类脂质渐进性坏死性血管病的新方法。
JAAD Case Rep. 2022 Aug 27;29:27-29. doi: 10.1016/j.jdcr.2022.08.031. eCollection 2022 Nov.